The Front Room — a clinical regulatory commons
RSS
GUIDELINE Step 4 Final

E2F Development Safety Update Report

E2F International Council for Harmonisation
ABSTRACT — EDITORS' SUMMARY

The DSUR standard — periodic safety reporting on drugs under development. Referenced by E6(R3) §3.13 for sponsor safety reporting obligations.

EMBEDDED PDF
Page of —
DownloadView on ICH ↗
Loading PDF…
METADATA
TypeGUIDELINE
Year2011
VersionStep 4 Final
StatusCurrent
FormatPDF
Pages—
Size—
Last reviewedSEP 2011
SOURCE
PDF · CANONICAL LINK https://database.ich.org/sites/default/files/E2F_Guideline.pdf ↗
RELATED · SAME AUTHORITY
ICH E6(R3) Annex 2
E6(R3) Annex 2 — Non-Traditional Interventional Clinical Trials
GUIDELINE 2025
ICH E20
E20 Adaptive Designs for Clinical Trials
GUIDELINE 2025
ICH E6(R3)
E6(R3) Good Clinical Practice — Step 4 Final Guideline
GUIDELINE 2025
ICH E19
E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-Approval or Post-Approval Clinical Trials
GUIDELINE 2022
ICH E9(R1)
E9(R1) Statistical Principles for Clinical Trials — Estimands Addendum
GUIDELINE 2019